Company · CIK 1783183
Phathom Pharmaceuticals, Inc.
| CIK | 1783183 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NJ |
| Listed | PHAT (Nasdaq) |
| First annual or quarterly report | 2019-11-25 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-292596 | 2026-01-07 | 2026-01-08 | 3 | |
| 333-275431 | 2023-11-09 | 2024-08-19 | 3 | |
| 333-250014 | 2020-11-10 | 2023-05-24 | 7 | |
| 333-234020 | 2019-09-30 | 2019-10-28 | 4 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-01-08 | 424B5Shelf takedown | 333-292596 | 0001193125-26-007653 |
| 2026-01-07 | 424B5Shelf takedown | 333-292596 | 0001193125-26-006403 |
| 2026-01-07 | S-3ASRShelf registered | 333-292596 | 0001193125-26-006262 |
| 2024-08-19 | 424B5Shelf takedown | 333-275431 | 0001193125-24-202873 |
| 2023-11-17 | EFFECTDeclared effective | 333-275431 | 9999999995-23-003382 |
| 2023-11-09 | S-3Shelf registered | 333-275431 | 0001193125-23-274478 |
| 2023-05-24 | 424B5Shelf takedown | 333-250014 | 0001193125-23-152941 |
| 2023-05-23 | 424B5Shelf takedown | 333-250014 | 0001193125-23-151884 |
| 2021-10-26 | 424B5Shelf takedown | 333-250014 | 0001193125-21-307940 |
| 2020-12-17 | 424B5Shelf takedown | 333-250014 | 0001193125-20-320089 |
| 2020-12-15 | 424B5Shelf takedown | 333-250014 | 0001193125-20-318224 |
| 2020-11-17 | EFFECTDeclared effective | 333-250014 | 9999999995-20-003211 |
| 2020-11-10 | S-3Shelf registered | 333-250014 | 0001193125-20-290314 |
| 2019-10-28 | 424B4Final prospectus | 333-234020 | 0001193125-19-274989 |
| 2019-10-24 | EFFECTDeclared effective | 333-234020 | 9999999995-19-002385 |
| 2019-10-15 | S-1/AAmendment | 333-234020 | 0001193125-19-267053 |
| 2019-09-30 | S-1Registration filed | 333-234020 | 0001193125-19-258922 |
| 2019-07-26 | DRSDraft made public | 377-02754 | 0000950123-19-006663 |